Literature DB >> 12135351

Role of zymogenicity-determining residues of coagulation factor VII/VIIa in cofactor interaction and macromolecular substrate recognition.

Ramona J Petrovan1, Wolfram Ruf.   

Abstract

Factor VIIa (VIIa) remains in a zymogen-like state following proteolytic activation and depends on interactions with the cofactor tissue factor (TF) for function. Val(21), Glu(154), and Met(156) are residues that are spatially close in available zymogen and enzyme structures, despite major conformational differences in the corresponding loop segments. This residue triad displays unusual side chain properties in comparison to the properties of other coagulation serine proteases. By mutagenesis, we demonstrate that these residues cooperate to stabilize the enzyme conformation and to enhance the affinity for TF. In zymogen VII, however, substitution of the triad did not change the cofactor affinity, further emphasizing the crucial role of the activation pocket in specifically stabilizing the active enzyme conformation. In comparison to VIIa(Q156), the triple mutant VIIa(N21I154Q156) had a stabilized amino-terminal Ile(16)-Asp(194) salt bridge and enhanced catalytic function. However, proteolytic and amidolytic activities of free VIIa variants were not concordantly increased. Rather, a negatively charged Asp at position 21 was the critical factor that determined whether an amidolytically more active VIIa variant also more efficiently activated the macromolecular substrate. These data thus demonstrate an unexpected complexity by which the zymogenicity-determining triad in the activation pocket of VIIa controls the active enzyme conformation and contributes to exosite interactions with the macromolecular substrate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135351     DOI: 10.1021/bi0202169

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Antibody-induced enhancement of factor VIIa activity through distinct allosteric pathways.

Authors:  Lisbeth M Andersen; Peter A Andreasen; Ivan Svendsen; Janneke Keemink; Henrik Østergaard; Egon Persson
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.

Authors:  Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

3.  Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.

Authors:  Daniel Kirchhofer; Michael T Lipari; Lydia Santell; Karen L Billeci; Henry R Maun; Wendy N Sandoval; Paul Moran; John Ridgway; Charles Eigenbrot; Robert A Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.

Authors:  Henry R Maun; Charles Eigenbrot; Helga Raab; David Arnott; Lilian Phu; Sherron Bullens; Robert A Lazarus
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

5.  Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.

Authors:  Anders B Sorensen; Inga Tuneew; L Anders Svensson; Egon Persson; Henrik Østergaard; Michael Toft Overgaard; Ole H Olsen; Prafull S Gandhi
Journal:  J Biol Chem       Date:  2019-12-04       Impact factor: 5.157

6.  A combined structural dynamics approach identifies a putative switch in factor VIIa employed by tissue factor to initiate blood coagulation.

Authors:  Ole H Olsen; Kasper D Rand; Henrik Østergaard; Egon Persson
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

7.  Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance.

Authors:  Prosenjit Sen; Pierre F Neuenschwander; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood Coagul Fibrinolysis       Date:  2010-06       Impact factor: 1.276

8.  Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.

Authors:  Egon Persson; Helle Bak; Anette Østergaard; Ole H Olsen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

9.  Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity.

Authors:  Jais R Bjelke; Ole H Olsen; Michel Fodje; L Anders Svensson; Susanne Bang; Gert Bolt; Birthe B Kragelund; Egon Persson
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

Review 10.  Exosites in the substrate specificity of blood coagulation reactions.

Authors:  P E Bock; P Panizzi; I M A Verhamme
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.